---
figid: PMC9354823__fphar-13-935536-g001
figtitle: 'Connections between metabolism and epigenetics: mechanisms and novel anti-cancer
  strategy'
organisms:
- NA
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
pmcid: PMC9354823
filename: fphar-13-935536-g001.jpg
figlink: /pmc/articles/PMC9354823/figure/F1/
number: F1
caption: 'Metabolism reprogramming in cancer cells. Metabolism reprogramming is characterized
  by a class of altered pathway, including enhanced glycolysis with increased lactate
  production, and enhanced pentose phosphate pathway, fatty acid synthesis, and glutamine
  metabolism. These metabolic pathways support energy supply and macromolecule biosynthesis,
  such as nucleotides, amino acids, and lipids. Metabolites that are produced by altered
  metabolism have the potential to control signaling or epigenetic pathways by regulating
  reactive oxygen species, acetylation, and methylation. Upregulated genes or proteins
  are labels red, whereas downregulated genes or proteins are labeled blue. GLUT,
  glucose transporter; MCT, monocarboxylate transporter; SLC1A5, solute carrier family
  1 member 5; TCA, Tricarboxylic acid cycle; G6PD, glucose-6-phosphate dehydrogenase;
  HK, hexokinase; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; PKM, pyruvate kinase
  M 2; LDH, lactate dehydrogenase; ACSS2, Acyl-CoA short-chain synthetase-2; ACSS1:
  Acyl-CoA short-chain synthetase-1; ACLY: ATP citrate lyase; GLS, glutaminase; GDH,
  glutamate dehydrogenase; PDC: pyruvate dehydrogenase complex; FH, fumarate hydratase;
  SDH, succinate dehydrogenase; IDH1/2, isocitrate dehydrogenase 1/2; HCY, homocysteine;
  PPP, pentose phosphate pathway; ATP, adenosine triphosphate; ADP, adenosine diphosphate;
  AMP, adenosine monophosphate; AMPK, AMP-activated protein kinase; OGT, O-GlcNAc
  transferase; OGA, O-GlcNAcase.'
papertitle: 'Connections between metabolism and epigenetics: mechanisms and novel
  anti-cancer strategy.'
reftext: Chen Chen, et al. Front Pharmacol. 2022;13:935536.
year: '2022'
doi: 10.3389/fphar.2022.935536
journal_title: Frontiers in Pharmacology
journal_nlm_ta: Front Pharmacol
publisher_name: Frontiers Media S.A.
keywords: cancer metabolism | epigenetics | immunity | novel anti-cancer strategy
  | oncology
automl_pathway: 0.9255224
figid_alias: PMC9354823__F1
figtype: Figure
redirect_from: /figures/PMC9354823__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9354823__fphar-13-935536-g001.html
  '@type': Dataset
  description: 'Metabolism reprogramming in cancer cells. Metabolism reprogramming
    is characterized by a class of altered pathway, including enhanced glycolysis
    with increased lactate production, and enhanced pentose phosphate pathway, fatty
    acid synthesis, and glutamine metabolism. These metabolic pathways support energy
    supply and macromolecule biosynthesis, such as nucleotides, amino acids, and lipids.
    Metabolites that are produced by altered metabolism have the potential to control
    signaling or epigenetic pathways by regulating reactive oxygen species, acetylation,
    and methylation. Upregulated genes or proteins are labels red, whereas downregulated
    genes or proteins are labeled blue. GLUT, glucose transporter; MCT, monocarboxylate
    transporter; SLC1A5, solute carrier family 1 member 5; TCA, Tricarboxylic acid
    cycle; G6PD, glucose-6-phosphate dehydrogenase; HK, hexokinase; GAPDH, glyceraldehyde-3-phosphate
    dehydrogenase; PKM, pyruvate kinase M 2; LDH, lactate dehydrogenase; ACSS2, Acyl-CoA
    short-chain synthetase-2; ACSS1: Acyl-CoA short-chain synthetase-1; ACLY: ATP
    citrate lyase; GLS, glutaminase; GDH, glutamate dehydrogenase; PDC: pyruvate dehydrogenase
    complex; FH, fumarate hydratase; SDH, succinate dehydrogenase; IDH1/2, isocitrate
    dehydrogenase 1/2; HCY, homocysteine; PPP, pentose phosphate pathway; ATP, adenosine
    triphosphate; ADP, adenosine diphosphate; AMP, adenosine monophosphate; AMPK,
    AMP-activated protein kinase; OGT, O-GlcNAc transferase; OGA, O-GlcNAcase.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - amon
  - rasp
  - rs
  - sxc
  - Oga
  - Zw
  - Hk
  - G6P
  - Gapdh2
  - Gpdh1
  - Gapdh1
  - Pep
  - bgcn
  - Ldh
  - CycE
  - cyc
  - sam
  - qkr54B
  - sls
  - Sam-S
  - sah
  - fh
  - ATPCL
  - ATPsynbeta
  - Atpalpha
  - LKRSDH
  - SdhB
  - SdhA
  - Sodh-2
  - SdhC
  - adp
  - Idh
  - Idh3b
  - Amph
  - Gdh
  - Gld
  - Desat2
  - Fadd
  - Fad2
  - Desat1
  - Fancd2
  - SNF4Agamma
  - AMPKalpha
  - GLS
  - OGT
  - EOGT
  - POMGNT1
  - POMGNT2
  - OGA
  - G6PD
  - UBL4A
  - GAPDH
  - GAPDHP44
  - PAEP
  - PREP
  - PTPN22
  - PKM
  - PKLR
  - LDHA
  - LDHB
  - LDHC
  - PDC
  - PNKD
  - ACSS1
  - ACSM3
  - ACSS2
  - FH
  - ACLY
  - ATP8A2
  - SARDH
  - SDHB
  - SORD
  - SDS
  - WDTC1
  - IDH1
  - IDH2
  - APRT
  - MFAP1
  - GLUD1
  - UGDH
  - H6PD
  - CRYL1
  - BRCA2
  - FANCD2
  - PSEN1
  - PRKAA1
  - PRKAA2
  - PRKAB1
  - PRKAB2
  - PRKAG1
  - PRKAG2
  - PRKAG3
  - GLS2
---
